替雷利珠单抗联合化疗对比帕博利珠单抗联合化疗一线治疗晚期肺鳞癌患者的疗效
朱玉斐,黄智昊,蔡依辰,曾云云,黄惠怡,孙钧,苏珊
The analysis of efficacy and safety of tislelizumab versus pembrolizumab with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma
Yufei ZHU,Zhihao HUANG,Yichen CAI,Yunyun ZENG,Huiyi HUANG,Jun SUN,Shan SU
实用医学杂志
.
2025, (7): 1024
-1029
.
DOI: 10.3969/j.issn.1006-5725.2025.07.014
